Guido Varoli

908 total citations
23 papers, 705 citations indexed

About

Guido Varoli is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Genetics. According to data from OpenAlex, Guido Varoli has authored 23 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Guido Varoli's work include Inhalation and Respiratory Drug Delivery (11 papers), Cystic Fibrosis Research Advances (11 papers) and Pneumonia and Respiratory Infections (8 papers). Guido Varoli is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Cystic Fibrosis Research Advances (11 papers) and Pneumonia and Respiratory Infections (8 papers). Guido Varoli collaborates with scholars based in Italy, France and Poland. Guido Varoli's co-authors include Francesco Manguso, Paolo Gionchetti, Massimo Campieri, Fernando Rizzello, P.A. Monici Preti, D. Valpiani, A. D’Arienzo, Vito Annese, Henryk Mazurek and T. Casetti and has published in prestigious journals such as The Journal of Pediatrics, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Guido Varoli

22 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Varoli Italy	13	379	304	271	131	121	23	705
Antoine Petitcollin France	16	120 0.3×	163 0.5×	98 0.4×	29 0.2×	108 0.9×	25	575
Amir Houshang Mohammad Alizadeh Iran	16	87 0.2×	438 1.4×	63 0.2×	16 0.1×	184 1.5×	41	762
Arjuna P. De Silva Sri Lanka	13	37 0.1×	331 1.1×	58 0.2×	51 0.4×	120 1.0×	28	583
Mehrdad Kashifard Iran	9	48 0.1×	67 0.2×	96 0.4×	12 0.1×	100 0.8×	27	320
S. Mazzuoli Italy	10	44 0.1×	121 0.4×	136 0.5×	78 0.6×	167 1.4×	24	393
Emily Prewett United Kingdom	14	103 0.3×	147 0.5×	157 0.6×	16 0.1×	371 3.1×	17	588
Krishnan MohanKumar United States	15	298 0.8×	73 0.2×	42 0.2×	20 0.2×	175 1.4×	24	657
Aharon Halak Israel	10	110 0.3×	182 0.6×	215 0.8×	24 0.2×	163 1.3×	11	488
Barbara Porowska Italy	12	153 0.4×	105 0.3×	61 0.2×	34 0.3×	466 3.9×	33	689
Jyotsna Joshi India	10	212 0.6×	75 0.2×	8 0.0×	91 0.7×	94 0.8×	77	476

Countries citing papers authored by Guido Varoli

Since Specialization

Citations

This map shows the geographic impact of Guido Varoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Varoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Varoli more than expected).

Fields of papers citing papers by Guido Varoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Varoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Varoli. The network helps show where Guido Varoli may publish in the future.

Co-authorship network of co-authors of Guido Varoli

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Varoli. A scholar is included among the top collaborators of Guido Varoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Varoli. Guido Varoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watz, Henrik, Anne‐Marie Kirsten, Andrea Ludwig-Sengpiel, et al.. (2024). Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial. Respiratory Research. 25(1). 378–378.

Ramanathan, Rangasamy, Manoj Biniwale, Krishnamurthy Sekar, et al.. (2020). Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. The Journal of Pediatrics. 225. 90–96.e1. 28 indexed citations

Sweet, David G., M. Turner, Zbyněk Straňák, et al.. (2020). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. The Journal of Maternal-Fetal & Neonatal Medicine. 35(24). 4739–4742. 5 indexed citations

Sweet, David G., M. Turner, Zbyněk Straňák, et al.. (2017). A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Archives of Disease in Childhood Fetal & Neonatal. 102(6). F497–F503. 51 indexed citations

Assche, Gert Van, Francesco Manguso, José Luis Cabriada, et al.. (2015). Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study. The American Journal of Gastroenterology. 110(5). 708–715. 44 indexed citations

Mazurek, Henryk, R. Chiron, А. Г. Чучалин, et al.. (2014). Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis. Pediatric Pulmonology. 49(11). 1076–1089. 21 indexed citations

Barnes, Neil, J.A. van Noord, Caterina Brindicci, et al.. (2013). Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination. Pulmonary Pharmacology & Therapeutics. 26(5). 555–561. 15 indexed citations

Mazurek, Henryk, et al.. (2012). Long-term efficacy and safety of tobramycin 300mg/4mL nebuliser solution in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. 40. 3376. 1 indexed citations

Brusasco, Vito, Giorgio Walter Canonica, Roberto W. Dal Negro, et al.. (2011). Formoterol by Pressurized Metered-Dose Aerosol or Dry Powder on Airway Obstruction and Lung Hyperinflation in Partially Reversible COPD. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24(5). 235–243. 6 indexed citations

10.

Cicirello, Helen, Henryk Mazurek, R. Chiron, et al.. (2011). Efficacy And Safety Of Two Inhaled Tobramycin Solutions In Patients With Cystic Fibrosis And Chronic Pseudomonas Aeruginosa Infection: Results From A Head To Head Comparison. A6121–A6121. 4 indexed citations

11.

Mazurek, Henryk, G. Lenoir, Guido Varoli, et al.. (2011). 110 Head-to-head comparison of two inhaled tobramycin solutions in cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (Pa) infection. Journal of Cystic Fibrosis. 10. S28–S28. 16 indexed citations

12.

Mazurek, Henryk, R. Chiron, Guido Varoli, et al.. (2011). 111 Comparison of two inhaled tobramycin solutions in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection: results in different age subgroups. Journal of Cystic Fibrosis. 10. S28–S28. 11 indexed citations

13.

Calverley, Peter M.A., Piotr Kuna, Eduard Monsó, et al.. (2010). Beclomethasone/formoterol in the management of COPD: A randomised controlled trial. Respiratory Medicine. 104(12). 1858–1868. 81 indexed citations

14.

Kashirskaya, N., et al.. (2008). Clinical importance of special aerosol formulation of tobramycin for treatment of chronic pulmonary disease in patients with cystic fibrosis. PULMONOLOGIYA. 20–26. 3 indexed citations

15.

Lenoir, G., et al.. (2007). Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosa. Pediatric Drugs. 9(Supplement 1). 11–20. 67 indexed citations

16.

Чучалин, А. Г., et al.. (2007). A Formulation of Aerosolized Tobramycin (Bramitob??) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection. Pediatric Drugs. 9(Supplement 1). 21–31. 68 indexed citations

17.

Gionchetti, Paolo, Agesilao D’Arienzo, Fernando Rizzello, et al.. (2005). Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine. Journal of Clinical Gastroenterology. 39(4). 291–297. 45 indexed citations

18.

Campieri, Massimo, D. Valpiani, A. D’Arienzo, et al.. (2003). Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study. Alimentary Pharmacology & Therapeutics. 17(12). 1471–1480. 81 indexed citations

19.

Rizzello, Fernando, Paolo Gionchetti, A. D’Arienzo, et al.. (2002). Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 16(6). 1109–1116. 103 indexed citations

20.

Rizzello, Fernando, Paolo Gionchetti, R Galeazzi, et al.. (2001). Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: A dose-finding study. Advances in Therapy. 18(6). 261–271. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact